MedTrace Logo

Genetic Biomarkers in Saliva Samples From Patients With Ewing Sarcoma

NCT01876303 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1650

Last updated 2016-07-14

No results posted yet for this study

Summary

This clinical trial studies genetic biomarkers from saliva samples in patients with Ewing sarcoma. Studying samples of saliva from patients with cancer in the laboratory may help doctors learn more about changes that occur in deoxyribonucleic acid (DNA) and identify biomarkers related to cancer.

Conditions

  • Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor (PNET)

Interventions

OTHER

laboratory biomarker analysis

Correlative studies

OTHER

questionnaire administration

Ancillary studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Joshua Schiffman, MD · Children's Oncology Group

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2016-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01876303 on ClinicalTrials.gov